Male Infertility Market: Trends and Forecasts up to 2024
professional career. In addition, development of advance technology to treat male infertility issues are responsible for driving growth in this region. Social taboos is one of the reason that pose threat to male infertility market. Furthermore increased awareness concerning male infertility treatment and rising medical tourism are some of the factors that can create growth opportunities in near future.
Geographically, Europe dominated the male infertility market in 2017. Europe attributed to the highest market share owing to presence of advance and well equipped fertility clinics, higher adoption of costlier treatments and high awareness level are the factors driving growth in this region. Asia Pacific is anticipated to be the fastest growing region owing to rising lifestyle associated disease and increase number of people focused on their professional career.
Segment Covered
The report on global male infertility market covers segments such as, test and treatment. On the basis of test the global male infertility market is categorized into DNA fragmentation technique, oxidative stress analysis, microscopic examination, sperm agglutination, computer-assisted semen analysis, sperm penetration assay and others. On the basis of treatment the global male infertility market is categorized into assisted reproductive technology( ART) and medication.
Geographic Coverage
The countries covered in the North America region include the U. S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U. K., France, Spain, and Rest of Europe are included in the European region. The U. S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x. x % over the period of 2018-2024.
Major Key Players Mentioned in this Premium Report
The report provides profiles of the companies in the global male infertility market such as, EMD Sereno, Inc., Endo International plc, Sanofi, Bayer Group, SCSA Diagnostics, Inc., Andrology Solutions, Halotech DNA SL, Intas Pharmaceuticals Ltd., Aytu BioScience, Inc. and Cadila Healthcare Ltd.
3 © Infinium Global Research